[{"id":"51666f07-e257-46bc-8e85-ae4fa60ad285","acronym":"","url":"https://clinicaltrials.gov/study/NCT05137275","created_at":"2021-11-30T12:53:36.156Z","updated_at":"2024-07-02T16:36:01.750Z","phase":"Phase 1","brief_title":"Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT05137275","lead_sponsor":"Shanghai East Hospital","biomarkers":" HER-2 • ER • ALK • PGR • IL6 • CD4 • IL2 • NCAM1 • IL10","pipe":" | ","alterations":" EGFR mutation","tags":["HER-2 • ER • ALK • PGR • IL6 • CD4 • IL2 • NCAM1 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IBR854"],"overall_status":"Recruiting","enrollment":" Enrollment 56","initiation":"Initiation: 11/24/2021","start_date":" 11/24/2021","primary_txt":" Primary completion: 04/01/2023","primary_completion_date":" 04/01/2023","study_txt":" Completion: 05/01/2023","study_completion_date":" 05/01/2023","last_update_posted":"2022-10-27"}]